Thu, August 15, 2019
Wed, August 14, 2019
Tue, August 13, 2019
Mon, August 12, 2019
Fri, August 9, 2019
Thu, August 8, 2019
Wed, August 7, 2019
Tue, August 6, 2019
Mon, August 5, 2019
Fri, August 2, 2019
Thu, August 1, 2019
Wed, July 31, 2019
Tue, July 30, 2019

Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $136 on, Aug 6th, 2019

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-136-on-aug-6th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $143 to $136 on, Aug 6th, 2019.

Matthew has made no other calls on BLUE in the last 4 months.



There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Jason McCarthy of "Maxim Group" Upgraded from Hold to Strong Buy and Held Target at $160 on, Tuesday, June 18th, 2019
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Decreased Target to $163 on, Monday, June 17th, 2019